Effects of Ketanserin Tartrate on Serum Lipids in Patients with Essential Hypertension
- 1 January 1988
- journal article
- clinical trial
- Published by Springer Nature in Drugs
- Vol. 36 (1) , 25-34
- https://doi.org/10.2165/00003495-198800361-00006
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- Serum Cholesterol During Ketanserin and Propranolol Administration in Hypertensive PatientsJournal of Cardiovascular Pharmacology, 1987
- Effects of antihypertensive drugs on plasma lipidsThe American Journal of Cardiology, 1987
- A Comparative and Long-Term Evaluation of Ketanserin in the Treatment of Essential HypertensionJournal of Cardiovascular Pharmacology, 1985
- Negative effects of diuretic drugs on metabolic risk factors for coronary heart disease: Possible alternative drug therapiesThe American Journal of Cardiology, 1983
- Vascular effects of ketanserin (R 41 468), a novel antagonist of 5-HT2 serotonergic receptors.1981
- Receptor binding profile of R 41 468, A novel antagonist at 5-HT2 receptorsLife Sciences, 1981
- Treatment of mild hypertension: results of a ten-year intervention trial.1977
- Effects of Treatment on Morbidity in HypertensionCirculation, 1972
- Effects of treatment on morbidity in hypertension. II. Results in patients with diastolic blood pressure averaging 90 through 114 mm Hg.1970
- Effects of treatment on morbidity in hypertension. Results in patients with diastolic blood pressures averaging 115 through 129 mm Hg.1967